1,3-Benzodioxolyl-N-methylpentanamine
From Wikipedia, the free encyclopedia
(Redirected from Methyl-K)
This article relies largely or entirely upon a single source. (June 2015) |
The topic of this article may not meet Wikipedia's general notability guideline. (June 2015) (Learn how and when to remove this template message) |
Names | |
---|---|
IUPAC name
1-(1,3-benzodioxol-5-yl)-N-methylpentan-2-amine
|
|
Other names
3,4-methylenedioxy-α-propyl-N-methyl-2-phenethylamine
|
|
Identifiers | |
3D model (Jmol)
|
|
ChemSpider | |
|
|
Properties | |
C13H19NO2 | |
Molar mass | 221.30 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
N-Methyl-1,3-benzodioxolylpentanamine (MBDP; Methyl-K, UWA-091), also known as 3,4-methylenedioxy-α-propyl-N-methylphenethylamine, is a psychoactive drug of the phenethylamine chemical class. It is the N-methyl analogue of 1,3-benzodioxolylpentanamine (BDP; K). Methyl-K was first synthesized by Alexander Shulgin ("Sasha" Shulgin). In his book PiHKAL ("Phenethylamines i Have Known And Loved"), the minimum dosage is listed as 100 mg, and the duration is unknown.[1] Very little is known about the pharmacology, pharmacokinetics, effects, and toxicity of Methyl-K.
See also[edit]
- Pentylone (bk-MBDP)
- Ethylbenzodioxolylpentanamine (EBDP; Ethyl-K)
- Methylbenzodioxolylbutanamine (MBDB; Methyl-J)
- UWA-101
References[edit]
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |